Betamethasone + Neomycin Sulphate

Edruc Ltd.

Product Code : 2145
MRP 18.00
10% Off
Best PriceTk
Out Of Stock


See All
Product Image
10% Off

Betaderm N0.1%+0.5%

Betamethasone + Neomycin Sulphate

Incepta Pharmaceuticals Ltd.

Add to cart
Product Image
10% Off

Betaval N0.1%+0.5%

Betamethasone + Neomycin Sulphate

Healthcare Pharmacuticals Ltd.

Add to cart
Product Image
10% Off


Betamethasone + Neomycin Sulphate

Biopharma Laboratories Ltd.

Add to cart
Product Image
10% Off


Betamethasone + Neomycin Sulphate

Ibn-Sina Pharmaceuticals Ltd.

Add to cart

Medicine overview

Indications of Betanosol-N 0.1%+0.5%

This topical preparation is indicated in eczema, prurigo nodularis, psoriasis, neurodermatoses, seborrhoeic dermatitis, contact sensitivity reactions, systemic steroid therapy in generalized erythroderma, secondarily infected insect bites & anal & genital intertrigo; specially when scondary bacterial infection is present.

Theropeutic Class

Aural steroid & antibiotic combined preparations


Betamethasone is an active topical corticosteroid which produces a rapid response in those infammatory dermatoses that are normally responsive to topical corticosteroid therapy, and is often efective in the less responsive conditions such as psoriasis. Neomycin sulphate is a broad spectrum bactericidal antibiotic efective against the majority of bacteria commonly associated with skin infections.

Dosage & Administration of Betanosol-N 0.1%+0.5%

Apply sparingly to the affected area 2 to 3 times daily until an improvement occurs. In children, course should be limited to 5 days


Acne vulgaris, Perioral dermatitis, Perianal and genital pruritus, Primary cutaneous viral infections (e.g. herpes simplex, chickenpox), Hypersensitivity to any component of the preparation.

Side Effects of Betanosol-N 0.1%+0.5%

Common side effects are burning, itching, irritation, dryness, folliculitis, hypertrychosis, acneiform eruptions, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria may be reported.

Pregnancy & Lactation

There are no adequate and well controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids and should not be used extensively for a prolonged period.

Precautions & Warnings

Long-term continuous topical therapy should be avoided where possible, particularly in infants and children. Infants and children up to four years should not be treated with topical steroids for longer than 3 weeks without medical review.

Storage Conditions

Protect from light and moisture. Keep out of reach of children.

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.